For the year ending 2025-12-31, PSTV has $16,325K in assets. $12,329K in debts. $4,256K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 4,256 | |||
| Restricted cash and cash equivalents | 4,502 | |||
| Investments | 4,356 | |||
| Grant receivable | 322 | |||
| Other current assets | 1,734 | |||
| Total current assets | 15,170 | |||
| Property and equipment, net | 257 | |||
| Operating lease right-use-of assets | 70 | |||
| Goodwill | 372 | |||
| Intangible assets, net | 333 | |||
| Other assets | 123 | |||
| Total assets | 16,325 | |||
| Accounts payable and accrued expenses | 5,920 | |||
| Investor liability pursuant to letter agreement | 4,502 | |||
| Operating lease liability | 56 | |||
| Deferred grant liability | 927 | |||
| Other liabilities | 159 | |||
| Line of credit | 750 | |||
| Total current liabilities | 12,314 | |||
| Noncurrent operating lease liability | 15 | |||
| Total liabilities | 12,329 | |||
| Common stock, 0.001 par value 2,000,000,000 shares authorized 138,934,281 shares issued and 138,675,856 outstanding as of december 31, 2025, 100,000,000 shares authorized 6,154,758 shares issued and 5,896,333 outstanding as of december 31, 2024, respectively | 139 | |||
| Treasury stock (at cost), 258,425 shares as of december 31, 2025 and 2024, respectively | 500 | |||
| Additional paid-in capital | 520,222 | |||
| Accumulated deficit | -515,865 | |||
| Total stockholders' equity (deficit) | 3,996 | |||
| Total liabilities and stockholders' equity | 16,325 | |||
PLUS THERAPEUTICS, INC. (PSTV)
PLUS THERAPEUTICS, INC. (PSTV)